— Know what they know.
/
Not Investment Advice
Also trades as: CURIW (NASDAQ) · $vol 0M

CURI NASDAQ

CuriosityStream Inc.
1W: +7.3% 1M: -10.0% 3M: +13.9% YTD: -25.8% 1Y: -36.2% 3Y: +397.7% 5Y: -70.2%
$2.80
+0.01 (+0.36%)
After Hours: $2.84 (+0.04, +1.61%)
Weekly Expected Move ±6.4%
$2 $3 $3 $3 $3
NASDAQ · Communication Services · Broadcasting · Tech Score Sell · Power 43 · $165.6M mcap · 31M float · 2.79% daily turnover · Short 43% of daily vol
Credit Risk of going bust: lower than 58% of companies Debt: 1.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.7%), CuriosityStream Inc. would be worth roughly what it owes.
Total debt $3.2M against a stock market value of $165.6M.
Distance to default 5.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.6M (short-term plus half of long-term), stock volatility 74.8%; Altman Z'' -15.06. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
65.0 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -0.0%  ·  5Y Avg: -29.6%
Cost Advantage
63
Intangibles
69
Switching Cost
84
Network Effect
54
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CURI has a Narrow competitive edge (65.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. Negative ROIC of -0.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$6
Avg Target
$6
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$5.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-15 Barrington Patrick Sholl $6 $5 -1 +96.1% $2.55
2025-10-28 Barrington Patrick Sholl Initiated $6 — +34.2% $4.47
2022-06-28 Stifel Nicolaus — Initiated $2 — +0.8% $1.99
2022-05-13 Needham — Initiated $3 — +61.3% $1.86

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 27, 2026
DCF
1
ROE
2
ROA
2
D/E
4
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CURI receives an overall rating of C+. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (2/5), ROA (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-26 C C+
2026-10-01 C+ C
2026-09-16 C C+
2026-08-18 C+ C
2026-08-13 C- C+
2026-05-14 D+ C-
2026-04-01 C- D+
2026-01-03 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 56 Grade A+
Profitability
60
Balance Sheet
81
Earnings Quality
77
Growth
75
Value
32
Momentum
100
Safety
0
Cash Flow
60
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CURI scores highest in Momentum (100/100) and lowest in Safety (0/100). An overall grade of A+ places CURI among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.23
Distress Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-3.01
Unlikely Manipulator
Ohlson O-Score
-7.04
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB-
Score: 53.0/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 224.83x
Accruals: -7.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CURI scores -2.23, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CURI scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CURI's score of -3.01 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CURI's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CURI receives an estimated rating of BBB- (score: 53.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CURI's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
14075.00x
PEG
908.79x
P/S
2.20x
P/B
4.02x
P/FCF
30.02x
P/OCF
29.88x
EV/EBITDA
9.81x
EV/Revenue
2.07x
EV/EBIT
270.28x
EV/FCF
29.34x
Earnings Yield
0.01%
FCF Yield
3.33%
Shareholder Yield
12.47%
Graham Number
$0.08
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14075.0x earnings, CURI is priced for high growth expectations. Graham's intrinsic value formula yields $0.08 per share, 3474% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.041
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
0.008
EBIT / Rev
×
Asset Turnover
1.040
Rev / Assets
×
Equity Multiplier
1.600
Assets / Equity
=
ROE
0.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CURI's ROE of 0.1% is driven by Asset Turnover (1.040), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.04 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$0.00
Price/Value
790.27x
Margin of Safety
-78926.77%
Premium
78926.77%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CURI's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CURI trades at a 78927% premium to its adjusted intrinsic value of $0.00, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 14075.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1710 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.80
Median 1Y
$1.74
5th Pctile
$0.49
95th Pctile
$6.27
Ann. Volatility
78.5%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Clint Stinchcomb,
President and Chief Executive Officer
 $677,014 $4,136,100 $5,608,442
Tia Cudahy, Counsel,
Counsel, Chief Operating Officer and Secretary
 $310,000 $614,963 $1,113,030
P. Brady Hayden,
Chief Financial Officer
 $203,750 $356,175 $660,819
Peter Westley, Financial
ancial Officer
 $129,167 $— $168,661

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,608,442
Avg Employee Cost (SGA/emp): $1,139,262
Employees: 42

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
42
-6.7% YoY
Revenue / Employee
$1,706,143
Rev: $71,658,000
Profit / Employee
$-153,024
NI: $-6,427,000
SGA / Employee
$1,139,262
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -48.8% -36.4% -21.5% -28.1% -31.7% -36.4% -33.1% -31.2% -56.7% -51.4% -51.9% -45.7% -21.3% -19.8% -12.1% -8.3% -10.0% -12.9% -17.1% 0.1% 0.05%
ROA -36.3% -24.6% -16.1% -20.3% -23.8% -27.4% -24.8% -22.9% -41.8% -38.3% -38.9% -34.2% -15.3% -13.8% -8.4% -5.6% -6.7% -7.9% -10.5% 0.0% 0.03%
ROIC -43.9% -51.3% -64.4% -80.5% -64.1% -64.9% -51.3% -44.7% -1.1% -89.6% -98.4% -93.7% -34.0% -35.0% -26.3% -20.1% -26.4% -16.2% -30.2% -0.0% -0.02%
ROCE -26.8% -30.9% -36.7% -41.6% -39.7% -42.0% -34.3% -32.9% -44.0% -32.9% -29.8% -22.7% -21.2% -21.1% -15.0% -11.2% -13.3% -14.5% -19.8% 1.2% 1.25%
Gross Margin 48.9% 36.8% 32.8% 41.9% 42.4% 9.4% 27.3% 29.5% 45.7% 45.0% 43.8% 51.6% 53.7% 52.1% 53.1% 53.4% 58.7% 60.5% 56.1% 72.8% 72.84%
Operating Margin -44.0% -66.0% -1.1% -71.8% -18.6% -1.1% -62.9% -56.9% -1.5% -32.3% -30.4% -20.6% -25.8% -27.4% 0.5% 2.5% -24.5% -17.6% -10.2% 39.5% 39.49%
Net Margin 4.4% -41.8% -90.2% -71.5% -19.1% -1.0% -62.6% -70.4% -1.7% -31.5% -42.0% -16.4% -24.3% -19.9% 2.1% 4.1% -20.4% -19.7% -8.8% 38.2% 38.21%
EBITDA Margin -3.2% -14.9% -58.1% -9.5% 26.0% -37.6% -14.6% -10.2% 3.7% 3.8% 14.0% 18.0% 11.0% 7.4% 24.1% 23.1% -2.2% 2.0% 15.7% 59.0% 59.05%
FCF Margin -1.1% -1.0% -92.9% -79.5% -68.7% -50.8% -46.2% -49.6% -39.6% -28.4% -16.3% -4.9% 5.0% 15.9% 17.2% 16.3% 18.1% 18.1% 17.2% 7.1% 7.07%
OCF Margin -1.1% -1.0% -92.4% -79.2% -68.5% -50.6% -46.1% -49.5% -39.6% -28.4% -16.3% -4.9% 5.0% 15.9% 17.3% 16.4% 18.2% 18.2% 17.2% 7.1% 7.10%
ROE 3Y Avg snapshot only -22.86%
ROE 5Y Avg snapshot only -27.25%
ROA 3Y Avg snapshot only -16.06%
ROIC 3Y Avg snapshot only -1.05%
ROIC Economic snapshot only -0.02%
Cash ROA snapshot only 8.00%
Cash ROIC snapshot only 14.27%
CROIC snapshot only 14.20%
NOPAT Margin snapshot only -0.01%
Pretax Margin snapshot only 0.77%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 60.75%
SBC / Revenue snapshot only 11.08%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -9.35 -7.26 -3.85 -1.84 -1.41 -1.04 -1.46 -1.18 -0.56 -0.51 -1.08 -1.41 -6.31 -6.17 -18.83 -65.27 -54.84 -34.09 -21.61 6717.28 14075.000
P/S Ratio 8.78 3.83 1.70 0.91 0.74 0.68 0.86 0.67 0.58 0.44 0.88 0.99 1.80 1.56 2.63 5.12 4.49 3.06 2.43 2.12 2.199
P/B Ratio 2.84 1.69 0.91 0.59 0.52 0.45 0.56 0.42 0.43 0.35 0.75 0.84 1.50 1.38 2.46 6.25 6.34 5.28 4.79 3.89 4.019
P/FCF -8.08 -3.71 -1.83 -1.14 -1.08 -1.33 -1.86 -1.35 -1.47 -1.55 -5.43 -20.00 36.24 9.79 15.31 31.37 24.83 16.91 14.16 30.02 30.016
P/OCF — — — — — — — — — — — — 36.24 9.79 15.18 31.13 24.67 16.78 14.13 29.88 29.877
EV/EBITDA -12.66 -8.23 -2.62 -0.33 -0.83 -0.20 -5.65 -1.34 0.37 3.97 11.09 3.71 10.93 8.20 13.69 27.48 31.80 26.68 23.96 9.81 9.805
EV/Revenue 7.32 2.70 0.71 0.07 0.09 0.03 0.25 0.05 -0.05 -0.15 0.27 0.34 1.24 1.02 2.09 4.72 4.13 2.98 2.25 2.07 2.074
EV/EBIT -8.10 -3.66 -0.99 -0.10 -0.16 -0.05 -0.46 -0.10 0.08 0.33 -0.72 -1.18 -4.51 -3.96 -12.09 -47.15 -40.51 -32.30 -20.21 270.28 270.281
EV/FCF -6.74 -2.61 -0.77 -0.08 -0.14 -0.06 -0.55 -0.11 0.13 0.51 -1.67 -6.91 24.89 6.38 12.17 28.95 22.85 16.46 13.10 29.34 29.338
Earnings Yield -10.7% -13.8% -26.0% -54.3% -70.7% -96.6% -68.5% -84.8% -1.8% -1.9% -92.4% -70.7% -15.9% -16.2% -5.3% -1.5% -1.8% -2.9% -4.6% 0.0% 0.01%
FCF Yield -12.4% -26.9% -54.7% -87.5% -92.3% -75.2% -53.9% -73.9% -68.0% -64.4% -18.4% -5.0% 2.8% 10.2% 6.5% 3.2% 4.0% 5.9% 7.1% 3.3% 3.33%
PEG Ratio snapshot only 908.785
Price/Tangible Book snapshot only 3.888
EV/OCF snapshot only 29.202
EV/Gross Profit snapshot only 3.295
Shareholder Yield snapshot only 12.47%
Graham Number snapshot only $0.08
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.51 2.36 2.21 1.92 2.19 2.25 2.31 2.21 2.03 1.94 2.00 2.17 1.90 1.66 1.87 1.66 1.62 1.23 0.95 0.78 0.784
Quick Ratio 2.45 2.36 2.21 1.92 2.19 2.25 2.31 2.21 2.03 1.94 2.00 2.17 1.90 1.66 1.87 1.66 1.62 1.23 0.95 0.78 0.784
Debt/Equity 0.00 0.00 0.03 0.04 0.04 0.04 0.04 0.04 0.06 0.06 0.06 0.06 0.06 0.07 0.07 0.08 0.08 0.30 0.10 0.08 0.078
Net Debt/Equity -0.47 -0.50 -0.53 -0.54 -0.45 -0.43 -0.40 -0.39 -0.47 -0.46 -0.52 -0.55 -0.47 -0.48 -0.50 -0.48 -0.50 -0.14 -0.36 -0.09 -0.088
Debt/Assets 0.00 0.00 0.02 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.16 0.05 0.05 0.048
Debt/EBITDA -0.00 -0.00 -0.23 -0.28 -0.46 -0.40 -1.40 -1.75 -0.54 -2.04 3.02 0.81 0.68 0.68 0.50 0.39 0.46 1.55 0.56 0.20 0.201
Net Debt/EBITDA 2.53 3.47 3.64 4.26 5.74 4.31 13.56 15.59 4.43 15.93 -24.90 -7.02 -4.99 -4.38 -3.53 -2.30 -2.75 -0.74 -1.95 -0.23 -0.227
Interest Coverage -2635.58 -37.35 -38.83 -39.01 -27.59 -91.63 -78.85 -74.36 — — — — — — — — — — — — —
Equity Multiplier 1.33 1.34 1.36 1.41 1.34 1.31 1.29 1.30 1.38 1.39 1.41 1.40 1.41 1.49 1.47 1.58 1.58 1.83 1.90 1.63 1.627
Cash Ratio snapshot only 0.330
Cash to Debt snapshot only 2.126
FCF to Debt snapshot only 1.661
Defensive Interval snapshot only 100.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.39 0.47 0.37 0.41 0.45 0.42 0.42 0.40 0.40 0.45 0.48 0.49 0.53 0.55 0.60 0.72 0.82 0.89 0.93 1.04 1.040
Inventory Turnover 20.68 11.87 — — 47.74 — — — — — — — — — — — — — — — —
Receivables Turnover 5.79 4.64 7.74 7.67 5.96 4.54 6.29 6.24 4.71 7.27 7.75 8.00 9.10 9.41 8.61 7.62 9.72 9.56 10.60 8.56 8.556
Payables Turnover 6.13 10.47 6.14 6.92 8.48 10.86 6.13 5.72 5.57 6.57 6.17 6.46 4.95 4.89 6.37 7.47 9.03 4.13 5.49 6.06 6.064
DSO 63 79 47 48 61 80 58 58 77 50 47 46 40 39 42 48 38 38 34 43 42.7 days
DIO 18 31 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 60 35 59 53 43 34 60 64 65 56 59 56 74 75 57 49 40 88 67 60 60.2 days
Cash Conversion Cycle 21 75 -12 -5 26 47 -2 -5 12 -5 -12 -11 -34 -36 -15 -1 -3 -50 -32 -18 -17.5 days
Fixed Asset Turnover snapshot only 25.785
Cash Velocity snapshot only 11.049
Capital Intensity snapshot only 0.888
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 95.8% 79.9% 87.6% 89.4% 64.1% 9.5% -7.8% -24.9% -37.7% -27.1% -22.4% -15.1% -8.5% -10.1% -4.0% 11.0% 28.6% 40.1% 32.3% 24.9% 24.86%
Net Income -1.3% 22.6% 37.4% 28.7% 8.2% -35.3% -23.0% 13.5% -23.0% 4.0% -8.0% -4.3% 74.8% 73.5% 83.6% 87.5% 63.1% 50.3% -6.4% 1.0% 1.01%
EPS 43.0% 29.3% 43.0% 28.5% 8.4% -34.9% -22.6% 13.9% -22.5% 4.4% -7.2% -3.1% 75.1% 75.2% 84.7% 88.4% 65.6% 51.3% -3.1% 1.0% 1.00%
FCF -68.1% -36.6% -66.7% -40.4% -3.7% 46.1% 54.1% 53.2% 64.1% 59.2% 72.7% 91.5% 1.1% 1.5% 2.0% 4.7% 3.7% 58.9% 32.0% -45.9% -45.91%
EBITDA -1.0% 18.7% 29.8% 52.6% 67.8% 49.9% 84.8% 85.0% 21.2% 82.0% 1.4% 3.0% 1.7% 4.0% 5.0% 1.1% 47.8% 26.0% -18.8% 53.7% 53.66%
Op. Income -1.2% -35.3% -35.4% -27.1% -15.7% -5.3% 23.2% 42.5% 4.9% 19.6% 7.4% 1.9% 74.2% 70.0% 76.2% 81.2% 45.1% 45.2% 7.0% 96.5% 96.55%
OCF Growth snapshot only -46.07%
Asset Growth snapshot only -14.22%
Equity Growth snapshot only -16.81%
Debt Growth snapshot only -20.93%
Shares Change snapshot only 5.67%
Dividend Growth snapshot only 18.24%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — 1.1% 49.0% 26.1% 12.8% 10.3% 6.5% -2.2% -10.5% -11.8% -10.9% -9.8% -2.8% -0.5% 5.6% 5.58%
Revenue 5Y — — — — — — — — — — — — — — 48.7% 25.5% 18.7% 12.6% 11.3% 10.9% 10.85%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — 71.3% 15.8% -2.9% -4.1% -2.7% -2.5% -7.1% -9.3% -6.2% -2.0% 1.0% 15.2% 19.4% 36.2% 36.22%
Gross Profit 5Y — — — — — — — — — — — — — — 42.8% 21.5% 15.7% 10.9% 10.3% 11.8% 11.76%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — 28.4% 28.1% 21.0% 4.5% -25.7% -26.7% -27.2% -26.6% -24.9% -25.2% -24.7% -21.1% -21.5% -20.3% -20.27%
Assets 5Y — — — — — — — — — — — — — — 4.8% 4.4% 4.5% -3.1% -21.4% -21.8% -21.83%
Equity 3Y — — — — — — 28.9% 28.5% 22.2% 17.3% -27.6% -27.3% -28.6% -29.0% -26.7% -27.9% -28.8% -29.3% -31.0% -26.1% -26.07%
Book Value 3Y — — — — — — -18.9% -19.3% -23.2% 13.5% -30.0% -27.6% -29.0% -30.7% -28.6% -29.9% -30.7% -31.4% -33.5% -29.3% -29.30%
Dividend 3Y — — — — — — — — — — — — — — — 1.2% 85.9% 70.6% 51.6% 3.0% 3.00%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — 1.00 0.98 0.99 0.88 0.84 0.64 0.37 0.20 0.08 0.00 0.10 0.71 0.30 0.23 0.15 0.23 0.34 0.69 0.685
Earnings Stability — — 0.28 0.36 0.63 0.03 0.26 0.10 0.73 0.09 0.29 0.05 0.01 0.36 0.01 0.12 0.21 0.61 0.70 0.89 0.893
Margin Stability — — 0.81 0.77 0.77 0.72 0.71 0.66 0.66 0.73 0.75 0.70 0.72 0.81 0.75 0.73 0.72 0.75 0.77 0.73 0.733
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 0.00 0.50 0.00 0.00 0.50 1.00 0.50 0.50 1.00 1.00 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0
Earnings Persistence — — 0.85 0.89 0.97 0.86 0.91 0.95 0.91 0.98 0.97 0.98 0.50 0.50 0.50 0.50 0.50 0.50 0.97 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — 0.04 0.02 0.06 0.22 -0.11 -0.02 -0.43 -0.34 -0.38 -0.25 0.33 0.33 0.41 0.38 0.39 0.29 0.19 0.34 0.344
Gross Margin Trend — — -0.18 -0.21 -0.20 -0.21 -0.19 -0.21 -0.19 -0.04 0.03 0.12 0.15 0.15 0.16 0.15 0.16 0.13 0.10 0.13 0.132
FCF Margin Trend — — 1.10 0.48 0.49 0.69 0.52 0.44 0.49 0.49 0.53 0.60 0.59 0.56 0.48 0.44 0.35 0.24 0.17 0.01 0.014
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — -42.1% -42.08%
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.15 1.95 2.10 1.60 1.30 0.78 0.78 0.87 0.38 0.33 0.20 0.07 -0.17 -0.63 -1.24 -2.10 -2.22 -2.03 -1.53 224.83 224.833
FCF/OCF 1.01 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 0.995
FCF/Net Income snapshot only 223.792
OCF/EBITDA snapshot only 0.336
CapEx/Revenue 0.6% 0.5% 0.5% 0.3% 0.2% 0.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.03%
CapEx/Depreciation snapshot only 0.002
Accruals Ratio 0.05 0.23 0.18 0.12 0.07 -0.06 -0.05 -0.03 -0.26 -0.26 -0.31 -0.32 -0.18 -0.23 -0.19 -0.17 -0.22 -0.24 -0.26 -0.07 -0.074
Sloan Accruals snapshot only -0.493
Cash Flow Adequacy snapshot only 0.280
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.5% 2.9% 5.1% 4.4% 4.9% 6.3% 10.0% 14.1% 11.9% 11.72%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.02 $0.05 $0.07 $0.11 $0.27 $0.33 $0.38 $0.42 $0.32 $0.33
Payout Ratio — — — — — — — — — — — — — — — — — — — 801.4% 801.42%
FCF Payout Ratio — — — — — — — — — — — — 1.0% 49.8% 68.0% 1.6% 1.6% 1.7% 2.0% 3.6% 3.58%
Total Payout Ratio — — — — — — — — — — — — — — — — — — — 837.7% 837.71%
Div. Increase Streak — — — — — — — — — — — 0 0 0 0 1 1 1 1 1 1
Chowder Number — — — — — — — — — — — — — — — 10.60 6.05 4.52 3.02 0.37 0.369
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.4% 0.6% 0.7% 0.6% 0.2% 0.3% 0.4% 0.3% 0.2% 0.1% 0.0% 0.0% 0.2% 0.5% 0.54%
Net Buyback Yield -19.3% -34.4% -0.1% -0.1% 0.0% 0.4% 0.4% 0.6% 0.7% 0.6% 0.2% 0.3% 0.4% 0.3% 0.2% 0.1% 0.0% 0.0% 0.2% 0.5% 0.54%
Total Shareholder Return -19.3% -34.4% -0.1% -0.1% 0.0% 0.4% 0.4% 0.6% 0.7% 0.6% 0.2% 2.7% 3.2% 5.4% 4.6% 5.0% 6.3% 10.0% 14.3% 12.5% 12.47%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.02 0.99 0.95 1.00 1.00 0.04 0.041
Interest Burden (EBT/EBIT) 1.04 0.71 0.61 0.72 0.87 0.98 1.06 1.02 1.61 1.90 2.14 2.39 1.03 0.98 0.79 0.79 0.85 0.97 1.01 1.00 1.000
EBIT Margin -0.90 -0.74 -0.72 -0.68 -0.60 -0.66 -0.55 -0.55 -0.64 -0.45 -0.38 -0.29 -0.27 -0.26 -0.17 -0.10 -0.10 -0.09 -0.11 0.01 0.008
Asset Turnover 0.39 0.47 0.37 0.41 0.45 0.42 0.42 0.40 0.40 0.45 0.48 0.49 0.53 0.55 0.60 0.72 0.82 0.89 0.93 1.04 1.040
Equity Multiplier 1.35 1.48 1.34 1.39 1.33 1.33 1.33 1.36 1.35 1.34 1.33 1.34 1.39 1.43 1.44 1.48 1.48 1.63 1.63 1.60 1.600
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.99 $-0.71 $-0.66 $-0.80 $-0.90 $-0.96 $-0.81 $-0.69 $-1.11 $-0.92 $-0.87 $-0.71 $-0.28 $-0.23 $-0.13 $-0.08 $-0.10 $-0.11 $-0.14 $0.00 $0.00
Book Value/Share $3.25 $3.08 $2.80 $2.52 $2.47 $2.23 $2.10 $1.94 $1.45 $1.37 $1.26 $1.21 $1.16 $1.02 $1.02 $0.87 $0.82 $0.72 $0.62 $0.68 $0.70
Tangible Book/Share $1.99 $1.62 $1.24 $1.02 $1.05 $0.93 $0.85 $0.74 $0.59 $0.52 $0.50 $0.52 $0.53 $0.47 $0.50 $0.37 $0.33 $0.72 $0.62 $0.68 $0.68
Revenue/Share $1.05 $1.35 $1.50 $1.63 $1.72 $1.48 $1.37 $1.22 $1.07 $1.07 $1.06 $1.02 $0.97 $0.90 $0.95 $1.06 $1.16 $1.24 $1.22 $1.25 $1.28
FCF/Share $-1.14 $-1.40 $-1.39 $-1.29 $-1.18 $-0.75 $-0.64 $-0.60 $-0.42 $-0.30 $-0.17 $-0.05 $0.05 $0.14 $0.16 $0.17 $0.21 $0.22 $0.21 $0.09 $0.09
OCF/Share $-1.14 $-1.39 $-1.38 $-1.29 $-1.18 $-0.75 $-0.63 $-0.60 $-0.42 $-0.30 $-0.17 $-0.05 $0.05 $0.14 $0.16 $0.17 $0.21 $0.23 $0.21 $0.09 $0.09
Cash/Share $1.53 $1.54 $1.57 $1.46 $1.21 $1.04 $0.92 $0.84 $0.76 $0.71 $0.73 $0.74 $0.62 $0.57 $0.59 $0.49 $0.48 $0.32 $0.29 $0.11 $0.12
EBITDA/Share $-0.61 $-0.44 $-0.41 $-0.32 $-0.19 $-0.22 $-0.06 $-0.05 $-0.15 $-0.04 $0.03 $0.09 $0.11 $0.11 $0.15 $0.18 $0.15 $0.14 $0.11 $0.27 $0.27
Debt/Share $0.00 $0.00 $0.09 $0.09 $0.09 $0.09 $0.09 $0.08 $0.08 $0.08 $0.08 $0.08 $0.07 $0.08 $0.07 $0.07 $0.07 $0.22 $0.06 $0.05 $0.05
Net Debt/Share $-1.53 $-1.54 $-1.48 $-1.37 $-1.12 $-0.95 $-0.83 $-0.75 $-0.68 $-0.63 $-0.65 $-0.66 $-0.54 $-0.49 $-0.51 $-0.42 $-0.41 $-0.10 $-0.22 $-0.06 $-0.06
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.229
Altman Z-Prime snapshot only -10.223
Piotroski F-Score 3 2 2 3 1 2 3 2 2 2 2 3 5 4 5 5 5 5 4 7 7
Beneish M-Score -0.76 0.52 -0.43 -1.43 -1.84 -1.95 -2.92 -2.59 -5.04 -5.04 -5.16 -5.23 -3.90 -3.49 -3.04 -2.35 -2.96 -3.44 -4.15 -3.01 -3.011
Ohlson O-Score snapshot only -7.043
Net-Net WC snapshot only $-0.16
EVA snapshot only $-3791444.77
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 64.72 44.62 32.17 29.76 32.69 31.95 33.65 34.35 45.49 43.64 40.91 45.49 52.60 52.77 51.81 60.16 61.75 50.72 53.68 52.97 52.972
Credit Grade snapshot only 10
Credit Trend snapshot only -7.183
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 56
Sector Credit Rank snapshot only 46

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms